IL22 and rheumatoid arthritis: Furthermore, it has also been informed that the therapy with disease-modifying drugs (leflunomide and methotrexate) diminished the increased levels of peripheral blood Th22 cells and serum IL-22 in patients with RA, which also correlated with diminution in disease activity [28].